Adicet Bio, Inc. (ACET) Financials

ACET Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 233.3 million 38.6 million
2023-06-30 277.6 million 38.6 million
2023-03-31 305.0 million 38.8 million
2022-12-31 330.7 million 38.4 million

ACET Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -22.1 million 5.6 million
2023-06-30 -26.4 million 5.0 million
2023-03-31 -26.0 million 4.8 million
2022-12-31 -25.3 million 4.3 million

ACET Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-09-30 -49.9 million
2023-06-30 -32.4 million
2023-03-31 -30.9 million
2022-12-31 -29.9 million

ACET Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 183.3 million - 21.8 million
2023-06-30 205.5 million - 22.6 million
2023-03-31 231.6 million - 23.5 million
2022-12-31 257.7 million - 21.0 million

ACET Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 43.0 million
2023-06-30 43.0 million
2023-03-31 43.0 million
2022-12-31 41.7 million

ACET Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 906000 26.2 million 6.6 million -
2023-06-30 1.5 million 28.4 million 6.5 million -
2023-03-31 1.9 million 26.8 million 6.6 million -
2022-12-31 6.5 million 25.0 million 6.6 million -

ACET Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 -25.0 million -

ACET

Price: $1.45

52 week price:
1.10
7.50

Payout Ratio Range:
-0.45%
77.04%

Earnings Per Share: -3.31 USD

P/E Ratio: -0.87

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 400300

Ebitda: 12.8 million

Market Capitalization: 119.1 million

Average Dividend Frequency: 2

Links: